The authors evaluated the safety and effectiveness of paclitaxel (Taxol) in combination with alisertib (MLN8237) for the treatment of advanced breast cancer (BC). The authors observed that a weekly, reduced dose of paclitaxel combined with alisertib improved the survival without cancer worsening in these patients.

This study aimed to evaluate the effectiveness of physical exercise in patients with prostate cancer. The study concluded that physical exercise is associated with reduction of tiredness, and improving functional capacity and quality of life in these patients.

This study investigated the effectiveness of robot-assisted left-hand training in older patients with stroke and hemispatial neglect (HN). Researchers suggested that robot-assisted hand training improves HN in these patients.

This study looked at the effect of different diets on the risk of a second stroke in patients who had already suffered one stroke. It found that the Mediterranean diet (MD), reduction of salt intake, and folic acid supplements may reduce the risk of a second stroke.

This study reviewed the current NCCN guidelines for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).

This study investigated the effect of low-density lipoprotein cholesterol (LDL-C) levels on hemorrhagic stroke risk. Researchers suggested that the use of intensive cholesterol-lowering therapy is not associated with an increased risk of hemorrhagic stroke.

This article looked at the use of physical activity (PA) in improving sleep problems in breast cancer (BC) survivors. The authors found that PA may be effective in improving sleep quality in BC survivors. 

This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity.

This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT.

This clinical trial is evaluating the safety and effectiveness of an experimental treatment, BXCL701, in combination with pembrolizumab (Keytruda) for people with small cell neuroendocrine prostate cancer (SCNPCa). The main outcome to be measured will be the response rate to the study treatment.